idiopath
pulmonari
fibrosi
ipf
chronic
progress
fibrot
interstiti
pneumonia
unknown
aetiolog
median
surviv
time
year
natur
cours
ipf
show
sever
clinic
characterist
slow
progress
stabl
stage
acut
exacerb
ipf
approxim
patient
ipf
develop
within
clinic
present
character
acut
respiratori
difficulti
within
day
lung
histopatholog
show
diffus
alveolar
damag
addit
fibrosi
mortal
rate
median
surviv
time
death
account
total
death
patient
thu
lead
caus
death
patient
ipf
whether
infect
induc
remain
elus
analys
use
microarray
multiplex
polymeras
chain
reaction
found
common
respiratori
virus
respiratori
track
patient
cytomegaloviru
respiratori
syncyti
viru
parainfluenza
viru
rhinoviru
previou
epidemiolog
studi
shown
occur
frequent
winter
spring
patient
use
indic
viru
infect
may
critic
factor
contribut
studi
use
anim
model
also
demonstr
mammal
herp
viru
infect
addit
lung
fibrosi
exacerb
lung
howev
anim
model
establish
serious
limit
investig
biolog
mechan
therapeut
intervent
previou
studi
use
twice
intratrach
administr
bleomycin
blm
success
establish
mous
model
found
level
balf
mice
increas
significantli
compar
mice
stabl
ipf
intraperiton
inject
antibodi
allevi
lung
inflamm
current
studi
aim
use
human
herp
simplex
viru
establish
mous
model
viru
investig
role
use
gene
knockout
mice
use
endoplasm
reticulum
stress
er
inhibitor
tauroursodeoxychol
acid
tudca
examin
contribut
er
mous
model
viru
develop
studi
use
effect
tool
develop
investig
new
therapi
specif
spf
grade
wt
male
mice
purchas
beij
vital
river
laboratori
anim
technolog
co
ltd
beij
china
male
knockout
mice
obtain
tokyo
univers
scienc
mice
hous
separ
cage
till
week
age
allow
access
water
food
freeli
protocol
mous
mainten
experi
approv
institut
anim
care
use
committe
tongji
univers
approv
wt
mice
random
four
group
acut
exacerb
b
stabl
fibrosi
blmsalin
c
viru
infect
alon
normal
control
salinesalin
mechanist
investig
wt
mice
random
two
addit
group
acut
exacerb
tudca
treatment
group
wt
mice
induc
develop
two
step
figur
lung
fibrosi
mous
blmsalin
group
administ
intratrach
mgkg
blm
blm
dalian
meilun
biotech
co
dalian
china
salin
mous
salinesalin
group
administ
volum
salin
manner
b
intranas
inocul
induc
day
blm
administr
accord
previou
descript
mcmillan
et
viru
stock
pfu
provid
institut
pasteur
shanghai
chines
academi
scienc
viral
titr
use
current
studi
base
previou
mix
dmem
media
intranas
inocul
mous
group
inocul
intranas
suspens
four
time
mous
salinesalin
blmsalin
group
administ
equal
volum
salin
accord
descript
et
mous
group
receiv
daili
intraperiton
inject
tudca
mgkg
darmstadt
germani
intranas
inocul
bronchoalveolar
lavag
fluid
balf
collect
day
day
blm
administr
day
day
blm
administr
centrifug
g
minut
supernat
harvest
store
futur
experi
left
lung
tissu
frozen
part
right
lung
tissu
use
determin
wet
dri
weight
ratio
remain
right
lung
tissu
fix
standard
tissu
fixat
solut
wuhan
goodbio
technolog
co
ltd
wuhan
china
hematoxylin
eosin
h
e
masson
stain
mice
use
collect
balf
lung
tissu
two
batch
experi
model
way
therefor
lung
tissu
use
wet
dri
ratio
histopatholog
perfus
salin
hour
fixat
paraembed
lung
tissu
section
prepar
use
h
e
masson
stain
stain
tissu
section
scan
leica
slide
scanner
leica
accord
report
mikawa
et
acut
lung
injuri
ali
score
h
e
stain
tissu
section
determin
masson
stain
score
determin
follow
criteria
estim
lung
fibrosi
sever
develop
ashcroft
et
two
pathologist
extens
experi
determin
ali
score
masson
stain
score
independ
averag
score
use
day
intratrach
administr
blm
wt
mice
mice
random
blmsalin
group
total
four
group
wtblmsalin
mous
surviv
record
start
infect
day
week
till
day
balf
supernat
centrifug
g
min
remov
precipit
supernat
harvest
protein
content
measur
bicinchonin
acid
bca
assay
micropl
reader
biotek
instrument
inc
winooski
vt
use
read
bca
assay
result
wavelength
nm
wet
weight
middl
lobe
right
lung
measur
dri
weight
measur
lung
tissu
dri
vacuum
freez
dryer
beij
sihuan
compani
beij
china
overnight
wetdri
weight
ratio
wet
weight
dri
weight
seven
mice
randomli
select
group
infect
day
day
day
day
inject
mlkg
pentobarbit
sodium
biotech
zhuhai
china
intraperiton
mice
anaesthet
tracheal
tube
place
measur
lung
function
use
mous
lung
function
analys
data
scienc
intern
inc
st
paul
mn
mous
vital
capac
vc
forc
vital
capac
fvc
forc
expiratori
volum
first
millisecond
dynam
pulmonari
complianc
cdyn
record
cell
collect
balf
centrifug
cell
count
coomassi
brilliant
blue
stain
suspend
fac
solut
fac
cell
suspens
divid
two
halv
one
half
use
label
antimous
antibodi
cell
surfac
half
label
antimous
cell
surfac
first
cell
fix
permeabil
cytoplasm
stain
antimous
antibodi
fluoresc
antibodi
purchas
ebiosci
san
diego
ca
cell
analys
flow
cytomet
beckman
coulter
brea
ca
mous
peripher
blood
collect
mononuclear
cell
pbmc
isol
erythrocyt
lyse
pbmc
analys
flow
cytometri
similar
manner
liquid
suspens
array
technolog
use
profil
cytokin
chemokin
balf
supernat
n
mice
group
cytokin
chemokin
list
liquid
suspens
array
includ
cc
chemokin
subfamili
eosinophil
chemotact
protein
eotaxin
kc
monocyt
chemoattract
protein
macrophag
inflammatori
regul
activ
normal
cell
express
rant
mous
cytokin
inflammatori
factor
measur
immunosorb
assay
elisa
neobiosci
shenzhen
china
lung
tissu
homogen
tissu
homogen
lyse
thoroughli
tissu
lysat
centrifug
supernat
collect
protein
concentr
supernat
determin
bca
assay
sampl
equal
amount
protein
load
gel
electrophoresi
protein
transfer
pvdf
membran
membran
probe
polyclon
antimous
antibodi
activ
transcript
factor
activ
transcript
factor
ccaatenhanc
bind
protein
cebp
homolog
protein
chop
antibodi
purchas
abcam
membran
probe
secondari
antibodi
chemiluminesc
signal
develop
signal
intens
measur
statist
analysi
softwar
graphpad
use
data
analys
continu
variabl
present
mean
standard
deviat
comparison
analys
independ
sampl
test
comparison
analys
anova
fisher
lsd
test
method
use
plot
surviv
curv
surviv
time
compar
test
p
consid
statist
signific
h
e
stain
reveal
damag
alveolar
structur
widen
alveolar
septum
mice
treat
blm
figur
b
lung
tissu
inflamm
group
wors
wtblmsalin
worst
day
day
mice
present
typic
characterist
includ
alveolar
septal
congest
oedema
inflammatori
cell
infiltr
lung
tissu
alveolar
epitheli
damag
appar
transpar
membran
structur
alveolar
caviti
figur
mice
show
less
inflammatori
cell
infiltr
lung
tissu
mice
figur
group
significantli
higher
ali
score
blmsalin
group
p
figur
mice
show
significantli
lower
ali
score
mice
p
figur
mice
develop
sever
inflamm
form
dens
aggreg
inflammatori
cell
week
infect
look
like
fibrosi
foci
thu
masson
stain
seem
mice
might
develop
sever
fibrosi
wtblmsalin
mice
figur
fibrosi
score
statist
significantli
differ
figur
addit
hydroxyprolin
content
measur
also
demonstr
similar
result
figur
data
suggest
infect
may
stimul
acut
lung
damag
may
exacerb
fibrosi
substanti
addit
infect
alon
also
caus
acut
inflamm
lung
tissu
figur
surviv
wt
mice
observ
day
day
inocul
intranas
week
surviv
rate
mice
significantli
lower
wtblmsalin
group
p
figur
notabl
surviv
rate
mice
significantli
higher
mice
p
figur
total
protein
balf
significantli
increas
blmsalin
group
figur
lung
tissu
wetdri
weight
ratio
figur
compar
mice
mice
significantli
reduc
total
protein
balf
p
figur
lung
tissu
wetdri
weight
ratio
figur
data
indic
infect
caus
lung
oedema
alveolar
epitheli
damag
protein
leakag
alveoli
appear
attenu
advers
effect
infect
day
fvc
group
decreas
significantli
compar
blmsalin
group
figur
cdyn
remain
similar
two
group
p
figur
infect
day
fvc
cdyn
group
reduc
significantli
compar
blmsalin
group
extent
lung
function
deterior
significantli
milder
mice
mice
infect
day
day
inflammatori
cell
collect
peripher
blood
balf
proport
inflammatori
monocyt
neutrophil
figur
neu
im
neutrophil
inflammatori
monocyt
macrophag
figur
cell
figur
cell
figur
analys
flow
cytometri
total
number
inflammatori
cell
balf
significantli
higher
group
blmsalin
group
figur
mice
inocul
number
macrophag
balf
increas
significantli
figur
fight
viru
infect
compar
macrophag
increas
healthi
mice
infect
inflammatori
monocyt
neutrophil
figur
lymphocyt
figur
recruit
appar
mice
indic
inflammatori
monocyt
neutrophil
lymphocyt
recruit
lung
may
associ
acut
lung
damag
proport
cell
cell
peripher
blood
group
increas
significantli
compar
three
group
figur
proport
cell
also
significantli
increas
blmsalin
group
p
figur
day
mice
significantli
fewer
lymphocyt
figur
inflammatori
monocyt
neutrophil
figur
balf
mice
result
indic
acut
lung
damag
could
associ
inflammatori
monocyt
neutrophil
chemotaxi
toward
lung
compar
blmsalin
group
group
demonstr
significantli
increas
figur
kc
figur
day
elev
kc
figur
figur
figur
figur
day
data
suggest
infect
may
caus
acut
pulmonari
inflamm
consequ
increas
inflammatori
factor
concentr
balf
inflammatori
factor
increas
highest
day
result
consist
histopatholog
result
day
mice
significantli
lower
kc
compar
mice
indic
may
contribut
acut
inflamm
fibrot
lung
endoplasm
reticulum
stress
er
occur
commonli
alveolar
epitheli
cell
patient
protein
overexpress
fibrot
lung
tissu
figur
blmsalin
mice
express
significantli
higher
level
p
figur
chop
p
figur
lung
tissu
salinesalin
mice
group
demonstr
significantli
higher
express
p
chop
p
p
figur
blmsalin
mice
tudca
inhibitor
er
use
tudca
treat
mice
group
express
significantli
lower
level
p
chop
p
p
mice
data
indic
er
may
activ
lung
fibrosi
stimul
tudca
attenu
er
model
h
e
stain
reveal
group
show
less
inflammatori
cell
infiltr
alveolar
septum
figur
milder
lung
tissu
inflamm
lower
ali
score
figur
group
wherea
sever
lung
fibrosi
remain
similar
two
group
figur
balf
group
contain
significantli
fewer
inflammatori
monocyt
neutrophil
figur
lower
proport
cell
peripher
blood
figur
reduc
level
figur
kc
figur
compar
balf
group
result
support
tudca
attenu
acut
lung
injuri
molecular
mechan
underli
benefici
effect
may
associ
inhibit
respons
product
recent
publish
diagnost
criteria
longer
emphas
exclus
evid
viru
infect
found
lung
tissu
patient
die
investig
role
viru
infect
establish
mous
model
inocul
intranas
mice
alreadi
develop
lung
fibrosi
one
week
infect
mice
show
obviou
diffus
lung
injuri
higher
ali
score
mice
stabl
lung
fibrosi
exacerb
lung
oedema
increas
protein
content
alveolar
caviti
diminish
lung
function
reduc
surviv
histolog
function
exacerb
mice
resembl
clinic
present
patient
diffus
lung
injuri
diminish
lung
function
reduc
surviv
rate
support
treatment
mimic
develop
close
previou
studi
shown
nasal
inocul
viru
addit
lung
fibrosi
result
lung
exacerb
lung
notabl
mammalian
viru
infect
anim
human
infect
addit
lung
fibrosi
may
mimic
develop
human
previou
studi
administ
lipopolysaccharid
lp
intratrach
mice
day
lung
fibrosi
mimic
postop
acut
exacerb
patient
interstiti
lung
howev
occur
rare
patient
current
studi
establish
mous
model
use
viru
infect
human
easili
infect
mice
alreadi
develop
stabl
mous
model
better
mimic
develop
patient
acut
pulmonari
inflamm
close
correl
factor
secret
predominantli
cell
lung
tissu
enhanc
inflammatori
respons
promot
inflammatori
monocyt
neutrophil
chemotaxi
clear
pathogen
howev
excess
inflammatori
respons
may
damag
neutrophil
inflammatori
monocyt
involv
pathogen
elimin
caus
acut
lung
inflamm
current
studi
data
indic
may
play
import
role
drive
lung
fibrosi
day
mice
respons
bleomycin
treatment
figur
data
seem
contradict
work
wilson
et
show
knockout
mice
refractori
lung
fibrosi
might
explain
demonstr
fact
format
obviou
lung
fibrosi
appear
day
administr
bleomycin
howev
wilson
colleagu
drew
conclus
evalu
fibrosi
day
administr
blm
prove
acut
inflammatori
period
contrast
observ
similar
degre
fibrosi
hydroxyprolin
content
wtblmsalin
group
day
administr
blm
suggest
might
contribut
acut
lung
injuri
fibrosi
studi
sandra
et
show
similar
conclus
previou
studi
found
experiment
silicosi
acut
alveol
induc
silica
depend
cytokin
appear
dispens
develop
late
fibrot
lung
respons
silica
compar
mice
treat
blmsalin
balf
mice
treat
contain
higher
level
may
promot
pathogen
cell
may
ultim
increas
proport
cell
peripher
blood
far
know
innat
immun
cell
cell
also
produc
innat
primari
immun
preliminari
studi
found
patient
higher
level
peripher
blood
patient
data
shown
thu
current
studi
focus
role
cell
model
current
studi
exclud
effect
produc
cell
cell
compar
wt
mice
mice
might
differ
level
cell
cell
cell
releas
larg
amount
promot
kc
secret
mobil
neutrophil
bone
marrow
peripher
kc
induc
chemotaxi
cell
particular
neutrophil
consequ
increas
inflammatori
monocyt
neutrophil
lymphocyt
balf
mice
exacerb
local
inflammatori
respons
lung
compar
wt
mice
mice
show
reduc
kc
concentr
balf
fewer
inflammatori
monocyt
neutrophil
balf
attenu
lung
inflamm
dysfunct
higher
surviv
rate
although
mice
show
significantli
higher
ali
score
mice
total
protein
balf
two
group
show
signific
differ
knockout
lead
reduct
number
infiltr
inflammatori
monocyt
neutrophil
balf
fewer
inflammatori
monocyt
neutrophil
balf
group
could
result
milder
alveolar
epitheli
injuri
thu
less
plasma
protein
exud
hand
total
protein
balf
one
index
evalu
ali
report
mikawa
et
ali
score
mainli
emphas
level
inflammatori
cell
infiltr
knockout
obvious
reduc
number
inflammatori
monocyt
neutrophil
balf
figur
howev
inflammatori
monocyt
neutrophil
account
small
proport
inflammatori
cell
balf
mice
inflammatori
cell
might
contribut
higher
ali
score
nevertheless
mice
show
significantli
lower
ali
score
mice
figur
thu
knockout
appear
partial
reliev
acut
lung
injuri
mice
result
show
knockout
might
influenc
clearanc
hsv
viru
figur
b
bagri
colleg
also
report
hsv
viral
titr
mice
significantli
differ
wt
mice
genit
hsv
howev
neither
result
bagri
work
actual
measur
lung
work
done
investig
effect
clearanc
hsv
detect
actual
viral
titr
lung
standard
method
plaqu
assay
futur
hypothes
could
key
mediat
excess
acut
inflamm
fibrot
lung
er
respons
protein
fold
disrupt
lead
accumul
unfold
protein
endoplasm
reticulum
er
consequ
develop
unfold
protein
respons
upr
moder
normal
upr
reduc
accumul
unfold
protein
er
restor
normal
physiolog
function
er
howev
excess
upr
may
trigger
inflammatori
previou
studi
found
concurr
herp
viru
infect
upr
alveolar
epitheli
cell
patient
ipf
suggest
viru
infect
may
contribut
alveolar
epitheli
injuri
exacerb
current
studi
found
compar
mice
treat
blmsalin
mice
treat
demonstr
significantli
elev
express
protein
particularli
higher
chop
express
lung
tissu
three
signal
pathway
involv
upr
perk
induc
chop
studi
overexpress
quit
obviou
mice
treat
jane
colleagu
found
chop
act
transcript
factor
stimul
express
previou
studi
demonstr
er
occur
aec
previou
studi
use
alveolar
epitheli
cell
establish
cell
model
found
infect
stimul
er
stress
pathway
aec
current
studi
mice
treat
increas
level
balf
compar
mice
treat
blmsalin
bind
receptor
cell
induc
cell
differenti
cell
consequ
increas
addit
found
er
inhibit
tudca
proport
cell
mous
peripher
blood
reduc
concentr
balf
decreas
acut
lung
injuri
also
attenu
find
indic
inhibit
er
allevi
lung
inflamm
probabl
take
effect
reduc
product
howev
previou
studi
respiratori
syncyti
viru
infect
anim
model
suggest
er
lung
tissu
increas
result
cleavag
matur
product
enhanc
secret
might
account
aggrav
report
acut
lung
injuri
er
activ
promot
kind
cytokin
secret
kc
till
studi
identifi
pathway
play
critic
role
work
done
explor
relationship
er
stress
inflamm
addit
studi
also
suggest
antibodi
treatment
gene
knockout
allevi
upr
lung
tissu
substanti
support
may
promot
er
lung
figur
studi
success
establish
mice
lung
fibrosi
found
er
play
key
role
acut
lung
injuri
studi
provid
anim
model
highli
mimic
human
facilit
investig
aetiolog
pathogen
mechan
intervent
author
confirm
conflict
interest
hp
li
weng
chen
h
qiu
mm
zhao
particip
concept
hypothesi
design
studi
chen
h
qiu
perform
experi
chen
h
qiu
mm
zhao
carri
statist
analys
author
contribut
interpret
data
chen
hp
li
wrote
manuscript
author
made
critic
revis
author
read
approv
final
manuscript
studi
approv
institut
ethic
committe
shanghai
pulmonari
hospit
